These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9639673)

  • 1. The form of iron oxide deposits in thalassemic tissues varies between different groups of patients: a comparison between Thai beta-thalassemia/hemoglobin E patients and Australian beta-thalassemia patients.
    St Pierre TG; Chua-anusorn W; Webb J; Macey D; Pootrakul P
    Biochim Biophys Acta; 1998 Jul; 1407(1):51-60. PubMed ID: 9639673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The magnetic susceptibilities of iron deposits in thalassaemic spleen tissue.
    Hackett S; Chua-anusorn W; Pootrakul P; St Pierre TG
    Biochim Biophys Acta; 2007 Mar; 1772(3):330-7. PubMed ID: 17291726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-temperature Mössbauer study of heterosite, (Fe, Mn)PO4.
    De Grave E; da Costa GM; Van Alboom A; Vandenberghe RE
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Jan; 100():104-8. PubMed ID: 22709937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of prolonged iron loading on the chemical form of iron oxide deposits in rat liver and spleen.
    Chua-anusorn W; Webb J; Macey DJ; de la Motte Hall P; St Pierre TG
    Biochim Biophys Acta; 1999 Jul; 1454(2):191-200. PubMed ID: 10381564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infrared spectroscopic studies of nanoscale iron oxide deposits isolated from human thalassemic tissues.
    Chua-anusorn W; Webb J
    J Inorg Biochem; 2000 Apr; 79(1-4):303-9. PubMed ID: 10830881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current management of thalassemia intermedia].
    Thuret I
    Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Blood Transfusion on Growth of Patients with Hb E/β-Thalassemia.
    Chuansumrit A; Sirachainan N; Kitpoka P; Kadegasem P; Songdej D; Sasanakul W; Wongwerawattanakoon P
    Hemoglobin; 2019; 43(4-5):264-272. PubMed ID: 31760834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-frequency low-field magnetic susceptibility of ferritin and hemosiderin.
    Allen PD; St Pierre TG; Chua-anusorn W; Ström V; Rao KV
    Biochim Biophys Acta; 2000 Feb; 1500(2):186-96. PubMed ID: 10657588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of spleen, spleen iron, and splenectomy for determining total body iron load, ferrikinetics, and iron toxicity in thalassemia major patients.
    Kolnagou A; Michaelides Y; Kontoghiorghe CN; Kontoghiorghes GJ
    Toxicol Mech Methods; 2013 Jan; 23(1):34-41. PubMed ID: 23039902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous chelation therapy during transplantation for thalassemia.
    Gaziev D; Giardini C; Angelucci E; Polchi P; Galimberti M; Baronciani D; Erer B; Maiello A; Lucarelli G
    Haematologica; 1995; 80(4):300-4. PubMed ID: 7590497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular adenoma in a beta-thalassemic woman having secondary iron overload.
    Shuangshoti S; Thaicharoen A
    J Med Assoc Thai; 1994 Feb; 77(2):108-12. PubMed ID: 7798835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular and hemostatic alterations associated with pulmonary hypertension in β-thalassemia hemoglobin E patients receiving regular transfusion and iron chelation.
    Uaprasert N; Satitthummanid S; Akkawat B; Sutcharitchan P; Rojnuckarin P
    Thromb Res; 2019 Feb; 174():104-112. PubMed ID: 30584959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination of various thalassemia syndromes and iron deficiency and utilization of reticulocyte measurements in monitoring response to iron therapy.
    Winichagoon P; Kumbunlue R; Sirankapracha P; Boonmongkol P; Fucharoen S
    Blood Cells Mol Dis; 2015 Apr; 54(4):336-41. PubMed ID: 25633854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia.
    Aessopos A; Kati M; Tsironi M; Polonifi E; Farmakis D
    Haematologica; 2006 May; 91(5 Suppl):ECR11. PubMed ID: 16709519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for noninvasive measurement of tissue iron in Cooley's anemia.
    Sheth S; Tang H; Jensen JH; Altmann K; Prakash A; Printz BF; Hordof AJ; Tosti CL; Azabagic A; Swaminathan S; Brown TR; Olivieri NF; Brittenham GM
    Ann N Y Acad Sci; 2005; 1054():358-72. PubMed ID: 16339684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of advanced glycation end products positively correlate with iron overload and oxidative stress markers in patients with β-thalassemia major.
    Mirlohi MS; Yaghooti H; Shirali S; Aminasnafi A; Olapour S
    Ann Hematol; 2018 Apr; 97(4):679-684. PubMed ID: 29318368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of BACH1 and Hemoglobin E/Beta-Thalassemia Globin Expression.
    Lee TY; Muniandy L; Teh LK; Abdullah M; George E; Sathar J; Lai MI
    Turk J Haematol; 2016 Mar; 33(1):15-20. PubMed ID: 26377036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure in beta-thalassemia syndromes: a decade of progress.
    Hahalis G; Alexopoulos D; Kremastinos DT; Zoumbos NC
    Am J Med; 2005 Sep; 118(9):957-67. PubMed ID: 16164878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The evolutionary effects of therapy on the skeletal lesions in beta-thalassemia].
    Orzincolo C; Castaldi G; Bariani L; Scutellari PN
    Radiol Med; 1994 Apr; 87(4):381-8. PubMed ID: 8190918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.